Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: A single institute experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 5, 2007, Pages 514-519

  Sasaki, Tomonari ^a   Nakamura, Katsumasa ^a   Shioyama, Yoshiyuki ^a   Toh, Yasushi ^b   Okamura, Ken ^b   Ohura, Hiroki ^a   Hirata, Hideki ^a   Honda, Hiroshi ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Radiotherapy; Salvage therapy; Stage I esophageal cancer

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CARBOPLATIN; CISPLATIN; FLUOROURACIL; NEDAPLATIN; TS 1; UFT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLON ADENOCARCINOMA; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; OVERALL SURVIVAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SALVAGE THERAPY; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 35148847348     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31805c1410     Document Type: Article

References (23)

1. Nemoto K, Yamada S, Nishio M, et al. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res. 2006;26:1507-1512.
2. Sugimachi K, Ohno S, Matsuda H, et al. Clinicopathologic study of early stage esophageal carcinoma. Br J Surg. 1989;76:759-763.
3. Holscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer: comparison between adeno- and squamous cell carcinoma. Cancer. 1995;76:178-186.
4. Nishimaki T, Tanaka O, Suzuki T, et al. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg. 1993;17:766-771; discussion 771-772.
5. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery. 1998;123:432-439.
6. Ohtsu A. Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol Jpn Soc Clin Oncol. 2004;9:444-450.
7. Okawa T, Tanaka M, Kita M, et al. Radiotherapy for superficial esophageal cancer. Int J Radiat Oncol Biol Phys. 1994;30:959-964.
8. Okawa T, Tanaka M, Kita-Okawa M, et al. Superficial esophageal cancer: multicenter analysis of results of definitive radiation therapy in Japan. Radiology. 1995;196:271-274.
9. Nemoto K, Matsumoto Y, Yamakawa M, et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience. Int J Radiat Oncol Biol Phys. 2000;46:921-925.
10. Nemoto K, Yamada S, Hareyama M, et al. Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Int J Radiat Oncol Biol Phys. 2001;50:639-644.
11. Ishikawa H, Sakurai H, Yamakawa M, et al. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone. J Clin Gastroenterol. 2005;39:495-500.
12. Shioyama Y, Nakamura K, Sasaki T, et al. Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience. Am J Clin Oncol. 2005;28:75-80.
13. Sai H, Mitsumori M, Araki N, et al. Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys. 2005;62:1339-1344.
14. Yamada K, Murakami M, Okamoto Y, et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:1106-1111.
15. Nishimura Y, Okuno Y, Ono K, et al. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma. Cancer. 1999;86:220-228.
16. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-1174.
17. Zhang Z, Liao Z, Jin J, et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:656-664.
18. Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg. 2001;25:424-431.
19. Perez CA, Brady LW, Halperin EC, et al, eds. Principles and Practice of Radiation Oncology, 4th ed. Philadelphia: Lippincot Williams & Wilkins; 2004.
20. Yamada K, Nemoto K, Takai Y, et al. Proposal for standard radiotherapy methods for superficial esophageal cancer: a multicenter retrospective evaluation. J Jpn Soc Ther Radiol Oncol. 2000;12:169-176.
21. Urschel JD, Ashiku S, Thurer R, et al. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer: a review. Dis Esophagus. 2003;16:60-65.
22. Swisher SG, Wynn P, Putnam JB, et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thoracic Cardiovasc Surg. 2002;123:175-183.
23. Okawa T, Dokiya T, Nishio M, et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan: Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys. 1999;45:623-628.